Sign in

CIK 0001006281 · Non-accelerated filer<br>Smaller reporting company

Protalix BioTherapeutics, Inc.

Sign in to watch
Ticker
PLX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
650643773
Phone
201-696-9345
Business address
2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
Former names
ORTHODONTIX INC, EMBASSY ACQUISITION CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2010-03-24 Shaaltiel Yoseph Executive VP, R&D Sale −202,700 $7.08 $1.4M 933,754
2010-03-23 Shaaltiel Yoseph Executive VP, R&D Sale −127,300 $7.02 $894K 1,136,454
2010-02-25 Maimon Yossi VP, Chief Financial Officer Grant or award · Stock Options (Right to Buy) +130,000 130,000
2010-02-25 Shaaltiel Yoseph Executive VP, R&D Grant or award · Stock Options (Right to Buy) +145,000 145,000
2010-02-25 Aviezer David President & CEO Grant or award · Stock Options (Right to Buy) +250,000 250,000
2010-02-25 Almon Einat Brill VP, Product Development Grant or award · Stock Options (Right to Buy) +130,000 130,000
2010-02-07 Lauterbach Sandra Leigh VP, Sales & Commercial Affairs Grant or award · Stock Options (Right to Buy) +160,000 160,000
2009-12-02 Bar-Shalev Amos Director Purchase +1,000 $8.68 $9K 1,000
2009-12-02 Bar-Shalev Amos Director Purchase +680 $8.20 $6K 1,680
2009-11-12 Hurvitz Eli Director Sale −1,121,967 $10.00 $11.2M 1,764,480
2009-11-12 Hurvitz Eli Director Sale −250,000 $10.76 $2.7M 1,514,480
2009-11-12 Hurvitz Eli Director Option exercise +3,384,502 $0.00 $3K 4,898,982
2009-11-12 Hurvitz Eli Director Shares withheld for taxes −299 $11.33 $3K 4,898,683
2009-11-12 Hurvitz Eli Director Other disposition −4,443,443 455,240
2009-11-12 Hurvitz Eli Director Option exercise · Stock Options (Right to Buy) −3,384,502 0
2009-10-21 Aviezer David CEO and President Sale −34,238 $9.36 $320K 0
2009-10-21 Aviezer David CEO and President Option exercise +247,490 $0.12 $30K 0
2009-10-21 Aviezer David CEO and President Shares withheld for taxes −3,253 $9.13 $30K 0
2009-10-21 Aviezer David CEO and President Option exercise · Stock Options (Right to Buy) −247,490 326,267
2009-10-20 Aviezer David CEO and President Sale −60,000 $9.45 $567K 0

Page 10 of 33 · 654 trades